⌘K

Login Start Free

Home/Filings/4/0000899243-21-023435

4//SEC Filing

Azelby Robert 4

Accession 0000899243-21-023435

CIK 0001466301other

View on SEC.gov Company Profile

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 9:07 PM ET

Size

5.2 KB

Accession

0000899243-21-023435

Insider Transaction Report

Form 4

Period: 2021-06-10

Clovis Oncology, Inc.CLVS

Director

Transactions

Award
Stock Option (right to buy)
2021-06-10+42,223→ 42,223 total
Exercise: $5.97Exp: 2031-06-10→ Common Stock (42,223 underlying)

Footnotes (1)

[F1]The options shall vest on the one-year anniversary of the date of grant.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Clovis Oncology, Inc.

CIK 0001466301

Entity typeother

Related Parties

1

filerCIK 0001656998

Filing Metadata

Form type: 4
Filed: Jun 10, 8:00 PM ET
Accepted: Jun 11, 9:07 PM ET
Size: 5.2 KB

View on SEC.gov